Copenhagen - Free Realtime Quote DKK

H. Lundbeck A/S (HLUN-B.CO)

32.92 +0.36 (+1.11%)
As of 4:30 PM GMT+2. Market Open.
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
19,912,000.00
19,912,000.00
18,246,000.00
16,299,000.00
17,672,000.00
Cost of Revenue
4,485,000.00
4,485,000.00
3,951,000.00
3,648,000.00
4,166,000.00
Gross Profit
15,427,000.00
15,427,000.00
14,295,000.00
12,651,000.00
13,506,000.00
Operating Expense
12,232,000.00
12,232,000.00
11,443,000.00
10,641,000.00
11,516,000.00
Operating Income
3,195,000.00
3,195,000.00
2,852,000.00
2,010,000.00
1,990,000.00
Net Non Operating Interest Income Expense
-11,000.00
-11,000.00
-143,000.00
-207,000.00
-243,000.00
Pretax Income
2,993,000.00
2,993,000.00
2,474,000.00
1,581,000.00
1,906,000.00
Tax Provision
703,000.00
703,000.00
558,000.00
263,000.00
325,000.00
Net Income Common Stockholders
2,290,000.00
2,290,000.00
1,916,000.00
1,318,000.00
1,581,000.00
Diluted NI Available to Com Stockholders
2,290,000.00
2,290,000.00
1,916,000.00
1,318,000.00
1,581,000.00
Basic EPS
2.31
--
1.93
1.33
7.96
Diluted EPS
2.31
--
1.93
1.33
7.96
Basic Average Shares
992,235.00
--
992,867.00
993,307.00
198,730.00
Diluted Average Shares
992,235.00
--
992,867.00
993,307.00
198,733.00
Total Operating Income as Reported
3,195,000.00
3,195,000.00
2,852,000.00
2,010,000.00
1,990,000.00
Total Expenses
16,717,000.00
16,717,000.00
15,394,000.00
14,289,000.00
15,682,000.00
Net Income from Continuing & Discontinued Operation
2,290,000.00
2,290,000.00
1,916,000.00
1,318,000.00
1,581,000.00
Normalized Income
2,310,655.00
2,310,655.00
2,074,670.00
1,477,294.00
1,449,111.75
Interest Income
86,000.00
86,000.00
22,000.00
7,000.00
6,000.00
Interest Expense
54,000.00
54,000.00
103,000.00
153,000.00
181,000.00
Net Interest Income
-11,000.00
-11,000.00
-143,000.00
-207,000.00
-243,000.00
EBIT
3,047,000.00
3,047,000.00
2,577,000.00
1,734,000.00
2,087,000.00
EBITDA
5,059,000.00
5,059,000.00
4,388,000.00
3,444,000.00
4,880,000.00
Reconciled Cost of Revenue
4,485,000.00
4,485,000.00
3,951,000.00
3,648,000.00
4,166,000.00
Reconciled Depreciation
2,012,000.00
2,012,000.00
1,811,000.00
1,710,000.00
2,793,000.00
Net Income from Continuing Operation Net Minority Interest
2,290,000.00
2,290,000.00
1,916,000.00
1,318,000.00
1,581,000.00
Total Unusual Items Excluding Goodwill
-27,000.00
-27,000.00
-205,000.00
-191,000.00
159,000.00
Total Unusual Items
-27,000.00
-27,000.00
-205,000.00
-191,000.00
159,000.00
Normalized EBITDA
5,086,000.00
5,086,000.00
4,593,000.00
3,635,000.00
4,721,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-6,345.00
-6,345.00
-46,330.00
-31,706.00
27,111.75
12/31/2020 - 6/10/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STENO.CO Stenocare A/S
4.8500
-2.81%
 
IPN.PA Ipsen S.A.
112.70
+0.36%
 
DAN.F Dancann Pharma A/S
0.0060
+11.11%
 
PHO.OL Photocure ASA
55.00
+1.10%
 
BIOG-B.ST BioGaia AB (publ)
114.20
+0.35%
 
SOBI.ST Swedish Orphan Biovitrum AB (publ)
278.80
-0.71%
 
MOB.ST Moberg Pharma AB (publ)
33.32
-2.40%
 
COLL Collegium Pharmaceutical, Inc.
36.34
+1.38%
 
ALVO Alvotech
14.16
+3.74%
 
MRK.DE Merck KGaA
151.95
+1.23%